Evidence map›Paper›PMID 41398432›Full record

ArticleScientific reports2025

A dual-functional cobalt ferrite nanocomplex for targeted cisplatin prodrug delivery and MALAT1 gene silencing in gastric cancer cells.

Fatemeh Doryani, Amirhossein Ahmadi, Hossein Nikmanesh, Fatemeh Azami, Ahmad Ghasemi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. High-coercivity CoCrScientific reports · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatemeh DoryaniDepartment of Biological Science and Technology, Persian Gulf University, Bushehr, 75169, Iran.
Amirhossein AhmadiDepartment of Biological Science and Technology, Persian Gulf University, Bushehr, 75169, Iran. ahahmadi@pgu.ac.ir.ORCID http://orcid.org/0000-0002-6113-5238
Hossein NikmaneshDepartment of Physics, Persian Gulf University, Bushehr, 75169, Iran. h.nikmanesh@pgu.ac.ir.ORCID http://orcid.org/0000-0001-5515-5702
Fatemeh AzamiDepartment of Biological Science and Technology, Persian Gulf University, Bushehr, 75169, Iran.
Ahmad GhasemiPersian Gulf Research Institute, Persian Gulf University, Bushehr, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cisplatin (CDDP) is a common drug for gastric cancer (GC) treatment. The aberrant expression of MALAT-1, a long noncoding RNA, plays a critical role in CDDP resistance. Thus, silencing MALAT-1 using short hairpin RNAs (shRNA) can be an effective way to overcome CDDP resistance. The present study aims to use magnetic cobalt ferrite nanoparticles (CoFe

Indexed as

CisplatinCobaltFerric CompoundsGene SilencingProdrugsRNA, Long NoncodingStomach NeoplasmsAntineoplastic AgentsApoptosisCell Line, TumorCell MovementCell SurvivalChitosanDrug Delivery SystemsHumansNanoparticlesAntineoplastic AgentsChitosanCisplatinCobaltcobalt ferriteFerric CompoundsMALAT1 long non-coding RNA, humanProdrugsRNA, Long NoncodingRNA, Small InterferingCobalt ferrite magnetic nanoparticleLncRNAPlatinum-based drugsShRNAStomach cancer

Identifiers

PMID41398432
PMCPMC12824278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.